Evidence map›Paper›PMID 31595633›Full record

ArticlePediatric blood & cancer2020

Improvement in processing speed following haploidentical bone marrow transplant with posttransplant cytoxan in children and adolescents with sickle cell disease.

Kemar V Prussien, Dilan A Patel, Karina Wilkerson, Becky Armstrong, Leena Karnik, Josu de la Fuente, Adetola A Kassim

Open access · greenAbstract readLetter
In one paragraph

Article in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Kemar V PrussienDepartment of Psychology and Human Development, Vanderbilt University, Nashville, Tennessee.
Dilan A PatelDivision of Hematology/Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.ORCID 0000-0003-0765-4990
Karina WilkersonDivision of Hematology/Oncology, Department of Medicine, Vanderbilt-Meharry Sickle Cell Disease Center of Excellence, Vanderbilt University School of Medicine, Nashville, Tennessee.
Becky ArmstrongDepartment of Paediatrics, St. Mary's Hospital, Imperial College, London, UK.
Leena KarnikDepartment of Paediatrics, St. Mary's Hospital, Imperial College, London, UK.
Josu de la FuenteDepartment of Paediatrics, St. Mary's Hospital, Imperial College, London, UK.
Adetola A KassimDivision of Hematology/Oncology, Department of Medicine, Vanderbilt-Meharry Sickle Cell Disease Center of Excellence, Vanderbilt University School of Medicine, Nashville, Tennessee.
St Mary's Hospital · GBVanderbilt University · USVanderbilt University Medical Center · US

Funding

LIFE-SPAN DEVELOPMENT OF NORMAL AND ABNORMAL BEHAVIORT32MH018921 · NIMH · VANDERBILT UNIVERSITY · PI HUMPHREYS, KATHRYN LEIGH · 1989 to 2024
$6.7M
VOLT (Vanderbilt Oncology Training Program)T32CA217834 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Douglas B Johnson · 2018 to 2026
$2.7M
NCI NIH HHS T32 CA217834NIMH NIH HHS T32 MH018921
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Postoperative CareAdolescentAnemia, Sickle CellBone Marrow TransplantationChildCyclophosphamideFemaleFollow-Up StudiesHistocompatibility TestingHumansImmunosuppressive AgentsMaleTreatment OutcomeCyclophosphamideImmunosuppressive Agents

Identifiers

PMID31595633
PMCPMC6868295
OpenAlexW2980172093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.